What does the evidence say about Garlic Cholesterol Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Garlic Cholesterol Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Also, total cholesterol (TC) was significantly reduced (WMD: -8.26; 95% CI: -14.65 to -1.88; I ² = 90.9%) based on 7 effect sizes, while changes in HDL-C, TG, and LDL-C were not significant overall. [Ebrahimzadeh A (2026); evidence level 1] - Moreover, longer duration of garlic supplementation significantly improved all lipid profiles in patients with T2DM. [Ebrahimzadeh A (2026); evidence level 1] - Background Garlic, as an additive, a spice, and an ancient herbal medicine, has been proposed as a potential treatment for type 2 diabetes mellitus (T2DM). [Ebrahimzadeh A (2026); evidence level 1] - This systematic review and meta-analysis provides a comprehensive evaluation of the effects of garlic supplementation on fasting blood sugar (FBS), hemoglobin A1c (HbA1c), and lipid profile in patients with T2DM. [Ebrahimzadeh A (2026); evidence level 1] - Objectives This systematic review and meta-analysis aimed to synthesize existing evidence, quantify the overall effect of garlic intervention on blood pressure, and explore potential variations in its effects under different population, formulation, and intervention duration conditions. [Tang Y (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.